.STUDY FEATURE.06 August 2024.
A large randomized regulated test with cisgender females highlights the problems of faithfulness to an everyday oral preexposure treatment program and also illustrates that twice-yearly injection of lenacapavir may maintain successful HIV prevention degrees over 6 months.